The premise
Between published evidence and the indication written on a prescription there is a distance that is almost never discussed in public. This talk is about that distance: why it exists, how it shows up in the consulting room, and what can be done about it with judgement and without cynicism.
It is not a talk about products or brands. It is a talk about how a clinical decision gets made when the guideline falls short, the patient does not match the trial population and the consultation lasts fifteen minutes.
Learning objectives
- Distinguish efficacy demonstrated in a trial from effectiveness expected in practice.
- Identify when a study population does not represent the patient in front of you.
- Read a composite endpoint without overestimating the benefit.
- Interpret effect size, number needed to treat, and absolute versus relative risk.
- Recognise the most frequent biases in promotional literature.
- Communicate uncertainty to the patient without losing credibility.
- Integrate practice guidelines, local evidence and clinical judgement in one decision.
- Build a personal, sustainable approach to staying current.
Available formats
| Format | Duration | Interaction | Mode |
|---|
| Keynote | 45 to 60 minutes | Questions at the close | In person or live stream |
| Extended talk | 90 minutes | Cases and discussion | In person preferred |
| Workshop | Half day | Group work with cases | In person |
Methodology
Content built on verifiable literature and real clinical practice cases. No product sponsorship, no mention of commercial brands, and sources cited in the participant material.
Audience
- General practitioners and specialists
- Healthcare staff
- Industry medical teams
- MSLs and Medical Affairs teams
- Academic institutions
- Scientific societies
Available for
- Congresses and medical meetings
- Internal sessions at pharmaceutical companies
- University and residency programmes
- Medical societies and professional colleges
- Regional events with live stream
Who delivers it
Dr. Byron Monzón López. Thirty years in the pharmaceutical industry across six companies in Latin America, more than 50 conferences delivered, editor of five scientific journals and active clinical practice in Guatemala City. Master's degree in Diabetes and Metabolic Syndrome.
